Keywords: hoffmann, la-roche, market, agouron, viracept, hoffmann-la, roche

Hoffmann La-Roche To Market Agouron's Viracept

Article | 27 January 1997

- Hoffmann-La Roche is to market Agouron Pharmaceuticals' anti-HIVprotease inhibitor drug Viracept (nelfinavir mesylate) in Europe and other countries. Agouron and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Roche

Go to company listing

Related Drugs

nelfinavir

Viracept

Go to drug listing